Sdei, F.; Bagnolini, G.; Falchi, F.; Sosic, A.; Fabbian, S.; Duca, M.; Bolognesi, M. L., Design and synthesis of small molecules targeting pre-miRNA21 toward the development of ribonuclease targeting chimeras (RIBOTACs) to regulate the oncogenic miRNA21, in: 1, 2025, pp. 1 - 1 (atti di: XXXII Young Research Fellows Meeting, Paris, February 2025) [Contribution to conference proceedings]
Masi, Mirco; Poppi, Laura; Previtali, Viola; Nelson, Shannon R; Wynne, Kieran; Varignani, Giulia; Falchi, Federico; Veronesi, Marina; Albanesi, Ennio; Tedesco, Daniele; De Franco, Francesca; Ciamarone, Andrea; Myers, Samuel H; Ortega, Jose Antonio; Bagnolini, Greta; Ferrandi, Giovanni; Farabegoli, Fulvia; Tirelli, Nicola; Di Stefano, Giuseppina; Oliviero, Giorgio; Walsh, Naomi; Roberti, Marinella; Girotto, Stefania; Cavalli, Andrea, Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activity, «CELL DEATH DISCOVERY», 2025, 11, Article number: 106 , pp. 1 - 23 [Scientific article]Open Access
Bagnolini G., Poppi L., Previtali V., Ferrandi G., Rinaldi F., Girotto S., Hirsch A.K.H., Roberti M., Cavalli A., A journey through targeting BRCA2-RAD51 protein-protein interaction to establish synthetic lethality as paradigm for anticancer drug discovery, in: National Congress of the Italian Chemistry Society 2024, 2024, pp. 1 - 999 (atti di: SCI 2024 Chemistry ELEMENTS OF FUTURE, Milano, 26/08/2024) [Contribution to conference proceedings]
Ferrandi, Giovanni; Poppi, Laura; Bagnolini, Greta; Previtali, Viola; Roberti, Marinella; Cavalli, Andrea, Design and synthesis of RAD51-BRCA2 disruptors to inhibit homologous recombination and achieve synthetic lethality in pancreatic cancer cells, in: XXVIII EFMC International Symposium on Medicinal Chemistry, 2024(atti di: XXVIII EFMC International Symposium on Medicinal Chemistry, Roma, 1st September 2024) [Poster]
Ferrandi, Giovanni; Poppi, Laura; Bagnolini, Greta; Falchi, Federico; Previtali, Viola; Girotto, Stefania; Roberti, Marinella; Cavalli, Andrea, Design and synthesis of RAD51-BRCA2 protein-protein interaction disruptors
to trigger synthetic lethality with Olaparib in pancreatic cancer cells, in: National Congress of the Italian Chemistry Society 2024, 2024(atti di: SCI 2024 Chemistry ELEMENTS OF FUTURE, Milano, 26th August 2024) [Poster]
Sdei, Federico; Bagnolini, Greta; Ghezzo, M.; Sosic, Alice; Sissi, Claudia; Bolognesi, MARIA LAURA, Design and synthesis of small molecules binders of pre-miRNA21 toward the regulation of oncogenic miRNA21, in: 1, 2024(atti di: EFMC ISMC XXVIII EFMC International Symposium on Medicinal Chemistry, Rome, 1-5 September 2024) [Poster]
Sdei, F.; Bagnolini, G.; Falchi, F.; Sosic, A.; Bolognesi, M. L., DESIGN AND SYNTHESIS OF SMALL MOLECULES TARGETING PRE-MIRNA21 TOWARD THE DEVELOPMENT OF RIBONUCLEASE TARGETING CHIMERAS (RIBOTACS) TO REGULATE THE ONCOGENIC MIRNA21, in: 1, 2024, pp. 1 - 1 (atti di: XXIII Giornata della chimica dell'Emilia-Romagna 2024, Modena, 19 December 2024) [Contribution to conference proceedings]
Previtali, Viola; Masi, Mirco; Poppi, Laura; Varignani, Giulia; Falchi, Federico; Tedesco, Daniele; Wynne, Kieran; Oliviero, Giorgio; Bagnolini, Greta; Farabegoli, Fulvia; DI STEFANO, Giuseppina; Girotto, Stefania; Roberti, Marinella; Cavalli, Andrea, Differential enantiomers activity of ARN24089 to achieve synthetic lethality in pancreatic cancer, in: 1, 2024(atti di: EFMC ISMC XXVIII EFMC International Symposium on Medicinal Chemistry, Rome, 1-5 September 2024) [Poster]
Previtali, Viola; Bagnolini, Greta; Ciamarone, Andrea; Ferrandi, Giovanni; Rinaldi, Francesco; Myers, Samuel Harry; Roberti, Marinella; Cavalli, Andrea, New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives, «JOURNAL OF MEDICINAL CHEMISTRY», 2024, 1, pp. 11488 - 11521 [Scientific article]Open Access
Sdei, Federico; Bagnolini, Greta; Falchi, Federico; Ghezzo, M.; Sosic, Alice; Sissi, Claudia; Roberti, Marinella; Bolognesi, MARIA LAURA, Targeting RNA degradation with small molecules: design and synthesis of selective RNA binders and development of ribonuclease targeting chimeras (RIBOTACs), in: 1, 2024(atti di: XXVIII Congresso Nazionale della Società Chimica Italiana - Elementi di Futuro, Milan, 26-30 August 2024) [Poster]
Myers, S. H.; Poppi, L.; Rinaldi, F.; Veronesi, M.; Ciamarone, A.; Previtali, V.; Bagnolini, G.; Schipani, F.; Ortega Martínez, J. A.; Girotto, S.; Di Stefano, G.; Farabegoli, F.; Walsh, N.; De Franco, F.; Roberti, M.; Cavalli, A., An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer, «EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY», 2023, 265, Article number: 116114 , pp. 1 - 20 [Scientific article]Open Access
Ferrandi, Giovanni; Bagnolini, Greta; Roberti, Marinella; Cavalli, Andrea, Design and synthesis of RAD51-BRCA disruptors to inhibit homologous recombination and achieve synthetic lethality in cancer cells, in: 42nd edition of European School of Medicinal Chemistry, ESMEC, 2023(atti di: European School of Medicinal Chemistry, ESMEC, Urbino, 2nd July 2023) [Poster]
Bagnolini, G; Luu, Tb; Hargrove, Ae, Recognizing the power of machine learning and other computational methods to accelerate progress in small molecule targeting of RNA, «RNA», 2023, 29, pp. 473 - 488 [Scientific article]
Bagnolini, G.; Falchi, F.; Sdei, F.; Roberti, M.; Sosic, A.; Sissi, C.; Bolognesi, M. L., Triggering RNA degradation with small molecules: development of RIBOnuclease TArgeting Chimeras (RIBOTACs), in: Book of abstract, 2023(atti di: XXVIII National Meeting on Medicinal Chemistry (NMMC28), Chieti, 17-20 September 2023) [Poster]
Bagnolini, G.; Balboni, B.; Schipani, F.; Gioia, D.; Veronesi, M.; De Franco, F.; Kaya, C.; Jumde, R. P.; Ortega, J. A.; Girotto, S.; Hirsch, A. K. H.; Roberti, M.; Cavalli, A., Identification of RAD51-BRCA2 Inhibitors Using N-Acylhydrazone-Based Dynamic Combinatorial Chemistry, «ACS MEDICINAL CHEMISTRY LETTERS», 2022, 13, pp. 1262 - 1269 [Scientific article]Open Access
